Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huoxue Xiaoyi Decoction (HXXYD) is a Traditional Chinese Medicine (TCM) herbal formula primarily utilized for the treatment of autoimmune thyroid disorders, specifically Hashimoto's thyroiditis and thyroid nodules. The decoction is composed of several botanical ingredients, typically including *Prunella vulgaris*, *Radix Scrophulariae*, *Radix Paeoniae Rubra*, and *Radix Curcumae*, which are selected for their synergistic effects in promoting blood circulation and resolving masses. Pharmacologically, HXXYD has been shown to modulate the immune microenvironment by restoring the balance between Th17 and Treg cells. This modulation leads to a significant reduction in the serum levels of thyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TGAb). Furthermore, the decoction exerts anti-inflammatory properties by downregulating pro-inflammatory cytokines such as IL-17 and upregulating anti-inflammatory cytokines like IL-10, thereby protecting thyroid follicular cells from autoimmune-mediated damage and reducing goiter volume.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on huoxuexiaoyi decoction.